Creditors and court approve Danish pharma restructuring

Copenhagen-based biopharmaceutical company Orphazyme has secured creditor and court approval of its restructuring proposal in Denmark, paving the way for it to sell its assets to US pharma group KemPharm.

Get unlimited access to all Global Restructuring Review content